However, as we found that SIN3B protein levels measured by IHC did not clearly correlate with GATA2 across a larger USC tumor cohort, it is likely that clinically relevant GATA2 regulation of SIN3B may not extend across the full USC tumor spectrum. This evidence concerns the gene GATA2 and neoplasm.